Skip to main content

Advances in High-Risk Cutaneous Squamous Cell Carcinoma

Please take this 1-question quiz before watching the video.

In this interview, Dr Vishal Patel discusses recent advances in high-risk cutaneous squamous cell carcinoma (CSCC), focusing on gene expression profiling (GEP) and promising treatment approaches. He highlights the evolving role of GEP in risk assessment and treatment decision-making, emphasizing the need for personalized approaches based on genetics, disease characteristics, and patient factors.


Please take the quiz again to assess your understanding after watching the video.

© 2025 HMP Global. All Rights Reserved.
Any views and opinions expressed are those of the author(s) and/or participants and do not necessarily reflect the views, policy, or position of The Dermatologist or HMP Global, their employees, and affiliates.